On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas

On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas

Submitted by admin on July 17, 2019 - 10:46am
Source: 
BioCentury
News Tags: 
Frequency Therapeutics
hearing loss
FX-322
Astellas
Headline: 
On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas
snippet: 

Frequency has found a partner in Astellas for its regenerative therapy to treat hearing loss in a deal that will support development of FX-322 as it moves into Phase IIa testing next quarter.

Do Not Allow Advertisers to Use My Personal information